UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
12.03
+0.95 (8.57%)
At close: Jun 13, 2025, 4:00 PM
12.15
+0.12 (1.00%)
After-hours: Jun 13, 2025, 7:59 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $554.67 million as of June 13, 2025. Its market cap has increased by 12.81% in one year.
Market Cap
554.67M
Enterprise Value
480.63M
1-Year Change
12.81%
Ranking
Category
Stock Price
$12.03
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $554.67M, an increase of 204.93%. That is a compound annual growth rate of 14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 510.90M | 13.68% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.32B |
| Johnson & Johnson | 378.60B |
| Novo Nordisk | 357.59B |
| AbbVie | 338.74B |
| UnitedHealth Group | 285.73B |
| Abbott Laboratories | 237.37B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |